BLOOMINGTON, Ind.--(BUSINESS WIRE)--In a study that confirms the critical role antibiotic-impregnated catheters can play to combat the significant worldwide death toll from catheter-related bloodstream infections (CRBSIs), a researcher from a world-renowned medical center has presented clinical evidence that these devices, in fact, reduce the risk of bacteremia and also the likelihood that bacteria could become resistant to the antibiotics used to prevent their colonization. Previously, some medical researchers had expressed concern that the use of these devices could promote antimicrobial resistance.
